These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 9447471

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
    Nilsson OR, Atterhög JH, Castenfors J, Jorfelt L, Karlberg BE, Thulin T, Tolagen K, Wettre S, Ohman KP.
    Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
    [Abstract] [Full Text] [Related]

  • 23. The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension.
    Jäättelä A, Baandrup S, Houtzagers J, Westergren G.
    J Clin Pharmacol; 1990 Feb; 30(S2):S66-71. PubMed ID: 2179283
    [Abstract] [Full Text] [Related]

  • 24. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI, Samoĭlenko VV, Osadchiĭ KK, Strizhakov LA.
    Ter Arkh; 2000 Feb; 72(9):78-80. PubMed ID: 11076427
    [No Abstract] [Full Text] [Related]

  • 25. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
    Tuininga YS, Crijns HJ, Brouwer J, van den Berg MP, Man in't Veld AJ, Mulder G, Lie KI.
    Circulation; 1995 Dec 15; 92(12):3415-23. PubMed ID: 8521562
    [Abstract] [Full Text] [Related]

  • 26. Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients.
    Silas JH, Freestone S, Lennard MS, Ramsay LE.
    Br J Clin Pharmacol; 1985 Oct 15; 20(4):387-91. PubMed ID: 4074607
    [Abstract] [Full Text] [Related]

  • 27. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ, Brewster LM, Koopmans RP, van Montfrans GA.
    Ned Tijdschr Geneeskd; 2005 Aug 06; 149(32):1808-9. PubMed ID: 16121668
    [Abstract] [Full Text] [Related]

  • 28. Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers.
    Aberg J, Abrahamsson B, Grind M, Nyberg G, Olofsson B.
    Eur J Clin Pharmacol; 1997 Aug 06; 52(6):471-7. PubMed ID: 9342583
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Lipophilic versus hydrophilic beta(1) blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction.
    Kardos A, Long V, Bryant J, Singh J, Sleight P, Casadei B.
    Heart; 1998 Feb 06; 79(2):153-60. PubMed ID: 9538308
    [Abstract] [Full Text] [Related]

  • 31. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
    Eagles CJ, Kendall MJ.
    Br J Clin Pharmacol; 1997 Mar 06; 43(3):291-300. PubMed ID: 9088584
    [Abstract] [Full Text] [Related]

  • 32. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.
    Head A, Maxwell S, Kendall MJ, Eagles C.
    Br J Clin Pharmacol; 1994 Dec 06; 38(6):499-504. PubMed ID: 7888287
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study.
    Tantucci C, Bruni B, Dottorini ML, Peccini F, Motolese M, Lecaillon JB, Sorbini CA, Grassi V.
    Am Heart J; 1990 Aug 06; 120(2):467-72. PubMed ID: 2200257
    [Abstract] [Full Text] [Related]

  • 36. [Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs].
    Lazebnik LB, Mikheeva OM, Drozdov VN, Petrakov AV, Sil'vestrova SIu.
    Eksp Klin Gastroenterol; 2008 Aug 06; (2):22-6. PubMed ID: 19148988
    [No Abstract] [Full Text] [Related]

  • 37. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
    Asplund J, Ohman P.
    Ann Clin Res; 1981 Aug 06; 13 Suppl 30():30-6. PubMed ID: 7027891
    [Abstract] [Full Text] [Related]

  • 38. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
    Löfdahl CG, Dahlöf C, Westergren G, Olofsson B, Svedmyr N.
    Eur J Clin Pharmacol; 1988 Aug 06; 33 Suppl():S25-32. PubMed ID: 2836204
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Complex assessment of efficacy and tolerance of metoprolol CR/ZOK in treating hypertension].
    Podzolkov VI, Strizhakov LA, Pavlov VI, Makolkin VI.
    Ter Arkh; 2002 Aug 06; 74(11):74-7. PubMed ID: 12498136
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.